Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 02-2026 | 11-2025 | 08-2025 | 05-2025 | 02-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,174 | -264,457 | -186,236 | -99,815 | -56,351 |
| Depreciation Amortization | 3,776 | 8,534 | 14,225 | 9,225 | 4,128 |
| Accounts receivable | N/A | N/A | N/A | -19,000 | N/A |
| Accounts payable and accrued liabilities | -461 | -630 | -3,655 | -5,888 | -3,209 |
| Other Working Capital | 3,898 | -31,596 | -30,046 | -46,507 | -14,029 |
| Other Operating Activity | 8,047 | 38,684 | 24,079 | 37,737 | 8,374 |
| Operating Cash Flow | $-71,914 | $-249,465 | $-181,633 | $-124,248 | $-61,087 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,045 | -14,002 | -8,871 | -6,160 | -3,485 |
| Purchase Of Investment | -255,934 | -455,688 | -281,350 | -178,351 | -110,183 |
| Sale Of Investment | 133,153 | 617,543 | 437,728 | 281,543 | 139,201 |
| Investing Cash Flow | $-123,826 | $147,853 | $147,507 | $97,032 | $25,533 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19,975 | 3,880 | 2,634 | 1,479 | 1,473 |
| Other Financing Activity | 0 | 234,762 | 0 | 0 | 0 |
| Financing Cash Flow | $19,975 | $238,642 | $2,634 | $1,479 | $1,473 |
| Beginning Cash Position | 247,928 | 110,898 | 110,898 | 110,898 | 110,898 |
| End Cash Position | 72,163 | 247,928 | 79,406 | 85,161 | 76,817 |
| Net Cash Flow | $-175,765 | $137,030 | $-31,492 | $-25,737 | $-34,081 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,914 | -249,465 | -181,633 | -124,248 | -61,087 |
| Capital Expenditure | -1,045 | -14,002 | -8,871 | -6,160 | -3,485 |
| Free Cash Flow | -72,959 | -263,467 | -190,504 | -130,408 | -64,572 |